12 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
GEMINI GXL
FDA 510(k)
FDA Class 2
·Radiology
GEMINI PET/CT Systems Upper Patient Pallet for the GEMINI GXL, 16 Slice and 6 Slice scanning device configurations. Model Numbers: 4535-679-71891 and 4535-6797591, 510(k) #K051170.
FDA Recall
Terminated
·Philips Medical Systems (Cleveland) Inc·Product code JAK·January 26, 2009
SP Profile drill, WN, long
FDA UDI
BIO CONCEPT Co., Ltd.·06947600301592·
APEX Knee System
FDA UDI
Omni Life Science, Inc.·00841690192367·Apex Revision Knee Reamer - Zimmer 17mm
Arthrex®
FDA UDI
ARTHREX, INC.·00888867427167·Dilator, 5.1 x 170mm
TSRH SPINAL SYSTEM
FDA 510(k)
FDA Class 2
·Orthopedic
SYNTHES 2.7 MM LC-DCP, 3.5 MM PROFILE
FDA 510(k)
FDA Class 2
·Orthopedic
SPRINT QUATTRO
FDA Adverse Event
Injury
·MPRI·Product code LWS·April 10, 2013
LIFEPAK 12 DEFIBRILLATOR/MONITOR SERIES
FDA Adverse Event
Malfunction
·PHYSIO-CONTROL, INC.·Product code MKJ·May 22, 2008
MAXIMO II VR
FDA Adverse Event
Malfunction
·MEDTRONIC S.A.·Product code LWS·April 12, 2011
Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone
FDA Enforcement
Class II
·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012
Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014